Clinical Trials in Dallas

Showing 10481-10500 of 17,468 trials

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

NCT03121144

This study describes a procedure to collect a subject's position, movement, physiological data and usability information using Masimo's investigational device.

Pressure UlcerPressure InjuryFalls Injury

Masimo Corporation34 participantsStarted Mar 2017

Dallas, Texas, United States

COMPLETEDPhase 3< 1 mile

Immunotherapy Study for Surgically Resected Pancreatic Cancer

NCT01072981

The purpose of this study is to assess overall survival after treatment with a regimen of adjuvant therapy (Gemcitabine alone or with 5-FU chemoradiation) with or without HyperAcute®-Pancreas (algenpantucel-L) immunotherapy in subjects who have undergone surgical resection.

Pancreatic Cancer

NewLink Genetics Corporation722 participantsStarted Apr 2010

Birmingham, Alabama, United States • Mobile, Alabama, United States • Tucson, Arizona, United States +72 more locations

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Find Trials by Condition in Dallas

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors

Vaccine Study for Surgically Resected Pancreatic Cancer

Transvenous Lead Removal Post-Market Clinical Study

Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

Pyruvate Kinase Deficiency Natural History Study

Community Central Line Infection Prevention Trial

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

INdividualized ITI Based on Fviii(ATE) Protection by VWF

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Comparing the ADR With Air Insufflation, Water Immersion and Water Exchange During Two-endoscopist Colonoscopy